246 related articles for article (PubMed ID: 33318015)
1. Development and Validation of an
Abd Algaffar SO; Verbon A; van de Sande WWJ; Khalid SA
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318015
[TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5- sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay.
Ahmed AO; van de Sande WW; van Vianen W; van Belkum A; Fahal AH; Verbrugh HA; Bakker-Woudenberg IA
Antimicrob Agents Chemother; 2004 Jul; 48(7):2742-6. PubMed ID: 15215141
[TBL] [Abstract][Full Text] [Related]
3. The performance and costs of XTT, resazurin, MTS and luciferin as viability dyes in in vitro susceptibility testing of Madurella mycetomatis.
Ma J; Eadie K; Fahal A; Verbon A; van de Sande WWJ
Trans R Soc Trop Med Hyg; 2024 May; ():. PubMed ID: 38721683
[TBL] [Abstract][Full Text] [Related]
4. Testing of the in vitro susceptibilities of Madurella mycetomatis to six antifungal agents by using the Sensititre system in comparison with a viability-based 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5- [(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay and a modified NCCLS method.
van de Sande WW; Luijendijk A; Ahmed AO; Bakker-Woudenberg IA; van Belkum A
Antimicrob Agents Chemother; 2005 Apr; 49(4):1364-8. PubMed ID: 15793113
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Disc Diffusion, Etest, and a Modified CLSI Broth Microdilution Method for
Nyuykonge B; van Amelsvoort L; Eadie K; Fahal AH; Verbon A; van de Sande W
Antimicrob Agents Chemother; 2021 Aug; 65(9):e0043321. PubMed ID: 34181477
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of Madurella mycetomatis to posaconazole and terbinafine.
van Belkum A; Fahal AH; van de Sande WW
Antimicrob Agents Chemother; 2011 Apr; 55(4):1771-3. PubMed ID: 21263050
[TBL] [Abstract][Full Text] [Related]
7. Melanin biosynthesis in Madurella mycetomatis and its effect on susceptibility to itraconazole and ketoconazole.
van de Sande WW; de Kat J; Coppens J; Ahmed AO; Fahal A; Verbrugh H; van Belkum A
Microbes Infect; 2007 Jul; 9(9):1114-23. PubMed ID: 17644456
[TBL] [Abstract][Full Text] [Related]
8. The combination of manogepix and itraconazole is synergistic and inhibits the growth of Madurella mycetomatis in vitro but not in vivo.
Konings M; Eadie K; Strepis N; Nyuykonge B; Fahal AH; Verbon A; van de Sande WWJ
Med Mycol; 2023 Nov; 61(11):. PubMed ID: 37960934
[TBL] [Abstract][Full Text] [Related]
9. Combining two antifungal agents does not enhance survival of Galleria mellonella larvae infected with Madurella mycetomatis.
Eadie K; Parel F; Helvert-van Poppel M; Fahal A; van de Sande W
Trop Med Int Health; 2017 Jun; 22(6):696-702. PubMed ID: 28342219
[TBL] [Abstract][Full Text] [Related]
10. Amphotericin B and terbinafine but not the azoles prolong survival in Galleria mellonella larvae infected with Madurella mycetomatis.
Kloezen W; Parel F; Brüggemann R; Asouit K; Helvert-van Poppel M; Fahal A; Mouton J; van de Sande W
Med Mycol; 2018 Jun; 56(4):469-478. PubMed ID: 28992315
[TBL] [Abstract][Full Text] [Related]
11. In vitro antifungal activity of isavuconazole against Madurella mycetomatis.
Kloezen W; Meis JF; Curfs-Breuker I; Fahal AH; van de Sande WW
Antimicrob Agents Chemother; 2012 Nov; 56(11):6054-6. PubMed ID: 22964246
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin.
Shi JY; Xu YC; Shi Y; Lü HX; Liu Y; Zhao WS; Chen DM; Xi LY; Zhou X; Wang H; Guo LN
Chin Med J (Engl); 2010 Oct; 123(19):2706-9. PubMed ID: 21034656
[TBL] [Abstract][Full Text] [Related]
13. Amphotericin B but not itraconazole is able to prevent grain formation in experimental Madurella mycetomatis mycetoma in mice.
van de Sande WW; van Vianen W; ten Kate M; Fahal A; Bakker-Woudenberg I
Br J Dermatol; 2015 Dec; 173(6):1561-2. PubMed ID: 26150103
[No Abstract] [Full Text] [Related]
14. Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species.
Wang HC; Hsieh MI; Choi PC; Wu CJ
J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30093391
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological cut-off values for itraconazole and ravuconazole for Madurella mycetomatis, the most common causative agent of mycetoma.
Nyuykonge B; Siddig EE; Mhmoud NA; Nyaoke BA; Zijlstra EE; Verbon A; Bakhiet S; Fahal AH; van de Sande WWJ
Mycoses; 2022 Dec; 65(12):1170-1178. PubMed ID: 36005544
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting DHN- and DOPA-melanin biosynthesis pathway increased the therapeutic value of itraconazole in Madurella mycetomatis infected Galleria mellonella.
Lim W; Konings M; Parel F; Eadie K; Strepis N; Fahal A; Verbon A; van de Sande WWJ
Med Mycol; 2022 Feb; 60(2):. PubMed ID: 35064672
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex.
Badali H; Fakhim H; Zarei F; Nabili M; Vaezi A; Poorzad N; Dolatabadi S; Mirhendi H
Mycopathologia; 2016 Apr; 181(3-4):235-40. PubMed ID: 26615417
[TBL] [Abstract][Full Text] [Related]
18. Madurella mycetomatis, the main causative agent of eumycetoma, is highly susceptible to olorofim.
Lim W; Eadie K; Konings M; Rijnders B; Fahal AH; Oliver JD; Birch M; Verbon A; van de Sande W
J Antimicrob Chemother; 2020 Apr; 75(4):936-941. PubMed ID: 31904836
[TBL] [Abstract][Full Text] [Related]
19. In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp.
Lewis RE; Wiederhold NP; Klepser ME
Antimicrob Agents Chemother; 2005 Mar; 49(3):945-51. PubMed ID: 15728887
[TBL] [Abstract][Full Text] [Related]
20. New species of Madurella, causative agents of black-grain mycetoma.
de Hoog GS; van Diepeningen AD; Mahgoub el-S; van de Sande WW
J Clin Microbiol; 2012 Mar; 50(3):988-94. PubMed ID: 22205798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]